Bharat Biotech to ramp up Covaxin production to additional 200 million doses

Bharat Biotech has decided to ramp up its production of COVID-19 vaccine Covaxin to an additional 200 million doses per year.

The anti-COVID vaccine will be produced at Chiron Behring Vaccines, Ankleshwar in Gujarat.

The product will likely be available from Q4 2021.



Leave a Reply

Your email address will not be published. Required fields are marked *

Our YouTube ChannelOur Facebook PageOur Twitter PageOur LinkedIn PageOur Instagram PageOur Whatsapp NumberYour Idea